A Johns Hopkins Children’s Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.
- Read more about Higher Dose Antibiotic Shown Safe in TB Patients Likely More Effective in Treating Deadliest Form of TB
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/higher-dose-antibiotic-shown-safe-in-tb-patients-likely-more-effective-in-treating-deadliest-form-of-tb
No comments:
Post a Comment